Vir Biotechnology (VIR) Presents at AASLD The Liver Meeting 2022

Safety, Tolerability, and Antiviral Activity of the siRNA VIR-2218 in Combination With the Investigational Neutralizing Monoclonal Antibody VIR-3434 For the Treatment of Chronic Hepatitis B Virus Infection: Preliminary Results From the Phase 2 MARCH Trial Edward Gane1, Alina Jucov2, Marta Dobryanska3, Ki Tae Yoon4, Tien-Huey Lim5, Andre Arizpe6, Daniel Cloutier6, Ling Shen6, Sneha V. Gupta6, Audrey H. Lau6, Carey Hwang6, Young-Suk Lim7 1Faculty of Medicine, University of Auckland, Auckland, New Zealand; 2Ar ...